Lunai Bioworks

(NASDAQ) ENOB

Current PriceN/A

Market CapN/A

Since IPO (2018)-100%

5 Year-99%

1 Year-90%

1 Month-22%

Lunai Bioworks Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$125.52M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

ENOB News

A researcher studying a sample in a petri dish

Why Enochian BioSciences Was a Winner on Monday

Eric VolkmanJun 21, 2021

Here's Why Enochian BioSciences Stock Skyrocketed Today

Joe TenebrusoJun 14, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lunai Bioworks

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David Weinstein

Website

www.renovarogroup.com

Headquarters

Los Angeles, CA 90067-2012, US

ENOB Financials

Key Financial Metrics (TTM)

Gross Margin

33%

Operating Margin

-706%

Net Income Margin

-651%

Return on Equity

-12%

Return on Capital

10%

Return on Assets

-19%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$188.97M

EBITDA

$177.15M

Operating Cash Flow

$7.87M

Capital Expenditure

$0.00

Free Cash Flow

$7.87M

Cash & ST Invst.

$92.70K

Total Debt

$10.17M

Lunai Bioworks Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$1.80M

+75.2%

EBITDA

$1.81M

+59.9%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$2.26M

+62.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$213.66K

-68.3%

Short Term Debt

$2.54M

-55.4%

Return on Assets

-18.83%

N/A

Return on Invested Capital

10.21%

N/A

Free Cash Flow

$1.07M

+58.1%

Operating Cash Flow

$1.07M

+58.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GRNAGreenLight Biosciences Holdings

GRNAGreenLight Biosciences Holdings$0.30-0.03%

RNTXRein Therapeutics Inc.

RNTXRein Therapeutics Inc.$1.03-23.99%

BLUEbluebird bio, Inc.

BLUEbluebird bio, Inc.$4.97+0.00%

SYRESpyre Therapeutics, Inc.

SYRESpyre Therapeutics, Inc.$69.42-6.76%

MGTAMagenta Therapeutics, Inc.

MGTAMagenta Therapeutics, Inc.$0.70-7.74%

ALVRAlloVir, Inc.

ALVRAlloVir, Inc.$9.81+4.14%

PSTIPluristem Therapeutics Inc.

PSTIPluristem Therapeutics Inc.$1.00-2.91%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About ENOB

What is the current price of Lunai Bioworks?

Lunai Bioworks is trading at N/A per share.

What is the 52-week range for Lunai Bioworks?

Over the past 52 weeks, Lunai Bioworks has traded between N/A and N/A.

How much debt does Lunai Bioworks have?

As of the most recent reporting period, Lunai Bioworks reported total debt of $2.75M.

How much cash does Lunai Bioworks have on hand?

Lunai Bioworks reported $491,645 in cash and cash equivalents in its most recent financial results.

What is Lunai Bioworks’s dividend yield?

Lunai Bioworks does not currently have a dividend yield.

Lunai Bioworks

Lunai Bioworks Financials at a Glance

ENOB News

Why Enochian BioSciences Was a Winner on Monday

Here's Why Enochian BioSciences Stock Skyrocketed Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lunai Bioworks

ENOB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lunai Bioworks Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ENOB

What is the current price of Lunai Bioworks?

What is the 52-week range for Lunai Bioworks?

How much debt does Lunai Bioworks have?

How much cash does Lunai Bioworks have on hand?

What is Lunai Bioworks’s dividend yield?

Premium Investing Services